Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center

Vanessa Z Ameen1, Bonnie F Pobiner, Gregory C Giguere

  • 1Clinical Pharmacology and Discovery Medicine, Research and Development, GlaxoSmithKline, Research Triangle Park, North Carolina 27709, USA. Vanessa.z.ameen@gsk.com

Paediatric Drugs
|August 11, 2006
PubMed

Insights

Children and adults preferred the citrus-flavored ranitidine effervescent tablets over peppermint-flavored ranitidine syrup. This improved taste acceptance may enhance medication administration and compliance in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Pharmacology
  • Drug Formulation

Background:

  • Ranitidine, a histamine H(2) receptor antagonist, is FDA-approved for gastroesophageal reflux disease in children.
  • New low-dose ranitidine effervescent tablets (25 mg) in citrus flavor are available for pediatric use.
  • A peppermint-flavored ranitidine syrup (15 mg/mL) is also available.

Purpose of the Study:

  • To compare taste preferences between ranitidine effervescent tablets and ranitidine syrup in children aged 4-8 years.
  • To assess adult caregivers' preferences for administering either ranitidine formulation based on taste.

Main Methods:

  • A randomized, single-blind, crossover taste test trial involving 102 children and 102 adult caregivers.
  • Subjects received a single 45 mg dose of each ranitidine formulation.
  • Children indicated their taste preference; adults answered questions regarding administration preference.

Main Results:

  • 71% of children preferred the taste of the effervescent tablets over the syrup (p < 0.001).
  • 71% of adults indicated a preference for administering the effervescent formulation based on taste.
  • Mild adverse events were reported, consistent with product labeling.

Conclusions:

  • The citrus-flavored ranitidine effervescent formulation is preferred over the peppermint-flavored syrup.
  • Improved taste acceptance of the effervescent tablets may improve pediatric medication administration and compliance.
Abstract

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
Drugs in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...